Facilitating implementation of organs-on-chips by open platform technology
Introduction Many Organ-on-Chip platforms are still not robust for all cell types, are not reproducible from experiment to
Get a better understanding and prediction for pre-clinical drug trials
Allowing comprehension and predicting of human responses earlier, while also offering ethical alternatives to animal testing.
Introduction Many Organ-on-Chip platforms are still not robust for all cell types, are not reproducible from experiment to
Introduction The authors present a simple and modular Microphysiological system without the use of complex components consisting of
Introduction The gut-liver axis is the bidirectional interaction that exists between the gut and its microbiota,
Introduction In vitro generation of perfusable 3D microvessels is an important goal for tissue engineering and
Introduction In postmenopausal women, fat mass and adipose-tissue mass (see Human Breast Adipocytes) are closely linked to obesity
Introduction Organ-on-Chips for Studying Tissue Barriers – Disruption of cell-formed tissue barriers is an essential part of
Introduction Obesity and obesity-related co-morbidities are on the rise globally, necessitating the development of novel treatments. White
Introduction Microfluidic 3D Endothelium-on-a-Chip – The endothelium is a thin membrane that lines the heart and
Introduction Human vascular microphysiological systems (MPS) represent promising three-dimensional in vitro models of normal and diseased vascular tissue.
Introduction Organ-on-a-Chip is a potential, multidisciplinary method for in-vitro modeling of disease, drug screening, and precision medicine
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com